The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Danaher (NYSE: DHR) has generated investment returns of around 200,000% over the last 40 years, outpacing the broader stock market by several multiples. The firm remains less famous than the major ...

To be sure, Danaher is not actually a biotech company. It sells tools, instruments, and services used by biotech and pharma companies to develop and manufacture drugs. It's essentially a ...

Danaher is an American healthcare company that manufactures and markets products used for advances in biotechnology, life sciences, and diagnostics. Danaher has increased its dividend for 13 ...

Irvine-based health technology and consumer electronics firm Masimo Corp. announced it entered into a definitive agreement to be acquired by healthcare company Danaher Corporation (Danaher). Under the ...

Global life sciences giant Danaher coughed up a pretty penny to buy Masimo this week, spending roughly $10 billion to beef up its diagnostics portfolio. The deal values medical device developer Masimo ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio. The acquisition values the device maker at $180 per share and ...

Danaher 's days in the portfolio may be numbered. We're again left disappointed after Danaher's latest acquisition plan failed to inspire Wall Street. Shares of the life sciences giant lost more than ...

Danaher Corp. agreed to buy Masimo Corp., in a deal with an enterprise value of about $9.9 billion, allowing it to gain a foothold in the medical supply business. Danaher will pay $180 per share in ...

Danaher could announce Masimo acquisition as early as Tuesday, FT reports Danaher valued at over $150 billion, Masimo at $7 billion Danaher previously acquired Abcam for $5.7 billion in 2023 Danaher ...